Loading chart…
PRE-MARKET
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services.
Metropolis Healthcare Limited (METROPOLIS) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The METROPOLIS share price is ₹576.90 (+1.03% today), with a market capitalisation of ₹120B and a price-to-earnings (P/E) ratio of 53.6. MarketRipple tracks the METROPOLIS investment thesis, the ripple-chain impact of market events on Metropolis Healthcare Limited, and the Healthcare sector outlook.
Open
₹575.50
High
₹580.00
Low
₹574.35
Prev. Close
₹571.00
52W High
₹609.05
52W Low
₹412.25
Day range
₹574.35–₹580.00
52-week range
₹412.25–₹609.05
Volume
23K
P/E
53.6
ROE
14.6%
D/E
0.15
Margin
12.6%
Metropolis Healthcare Limited (NSE: METROPOLIS) is currently trading at ₹576.90 (+1.03%).
Metropolis Healthcare Limited's market capitalization is ₹120B.
Metropolis Healthcare Limited's price-to-earnings (P/E) ratio is 53.6.
Metropolis Healthcare Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Metropolis Healthcare Limited currently reads positive, based on 19 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.